Comparative analysis of the virulence control systems of Bordetella pertussis and Bordetella bronchiseptica

被引:87
|
作者
deTejada, GM [1 ]
Miller, JF [1 ]
Cotter, PA [1 ]
机构
[1] UNIV CALIF LOS ANGELES,SCH MED,DEPT MICROBIOL & IMMUNOL,LOS ANGELES,CA 90095
关键词
D O I
10.1046/j.1365-2958.1996.01538.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bordetella pertussis and Bordetella bronchiseptica contain nearly identical BvgAS signal-transduction systems that mediate a biphasic transition between virulent (Bvg(+)) and avirulent (Bvg(-)) phases. In the Bvg(+) phase, the two species express a similar set of adhesins and toxins, and in both organisms the transition to the Bvg(-) phase occurs in response to the same environmental signals (low temperature or the presence of nicotinic acid or sulphate anion). These two species differ, however, with regard to Bvg(-)-phase phenotypes, host specificity, the severity and course of the diseases they cause, and also potentially in their routes of transmission. To investigate the contribution of the virulence-control system to these phenotypic differences, we constructed a chimeric B. bronchiseptica strain containing bvgAS from B. pertussis and compared it with wild-type B. bronchiseptica in vitro and in vivo. The chimeric strain was indistinguishable from the wild type in its ability to express Bvg(+)- and Bvg(-)-phase-specific factors. However, although the chimeric strain responded to the same signals as the wild type, it differed dramatically in sensitivity to these signals; significantly more nicotinic acid or MgSO4 was required to modulate the chimeric strain compared with the wild-type strain. Despite this difference in signal sensitivity, the chimeric strain was indistinguishable from the wild type in its ability to cause respiratory-tract infections in rats, indicating that the bvgAS loci of B. pertussis and B. bronchiseptica are functionally interchangeable in vivo. By exchanging discrete fragments of bvgAS, we found that the periplasmic region of BvgS determines signal sensitivity.
引用
收藏
页码:895 / 908
页数:14
相关论文
共 50 条
  • [21] VIRULENCE FACTORS OF BORDETELLA-PERTUSSIS
    MOOI, FR
    ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY, 1988, 54 (05): : 465 - 474
  • [22] Bordetella pertussis virulence factors.
    Locht, C
    MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 : 20S - 28S
  • [23] Molecular genetics of Bordetella pertussis virulence
    Scarlato, V
    Beier, D
    Rappuoli, R
    METHODS IN MICROBIOLOGY, VOL 27, 1998, 27 : 395 - 406
  • [24] VIRULENCE FACTORS OF BORDETELLA-PERTUSSIS
    WEISS, AA
    HEWLETT, EL
    ANNUAL REVIEW OF MICROBIOLOGY, 1986, 40 : 661 - 686
  • [25] The BvgASR virulence regulon of Bordetella pertussis
    Chen, Qing
    Stibitz, Scott
    CURRENT OPINION IN MICROBIOLOGY, 2019, 47 : 74 - 81
  • [26] The Bvg virulence control system regulates biofilm formation in Bordetella bronchiseptica
    Irie, Y
    Mattoo, S
    Yuk, MH
    JOURNAL OF BACTERIOLOGY, 2004, 186 (17) : 5692 - 5698
  • [27] Purification, spectroscopic analysis and biological activity of the macrocyclic dihydroxamate siderophore alcaligin produced by Bordetella pertussis and Bordetella bronchiseptica
    Brickman, TJ
    Hansel, JG
    Miller, MJ
    Armstrong, SK
    BIOMETALS, 1996, 9 (02) : 191 - 203
  • [28] Polymorphism of repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica (vol 68, pg 4815, 2000)
    Boursaux-Eude, C
    Guiso, N
    INFECTION AND IMMUNITY, 2000, 68 (12) : 7214 - 7214
  • [29] Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis Tohama I in murine models of respiratory tract infection
    Harvill, ET
    Cotter, PA
    Miller, JF
    INFECTION AND IMMUNITY, 1999, 67 (11) : 6109 - 6118
  • [30] Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations
    Chamorro, Beatriz Miguelena
    De Luca, Karelle
    Swaminathan, Gokul
    Longet, Stephanie
    Mundt, Egbert
    Paul, Stephane
    CLINICAL MICROBIOLOGY REVIEWS, 2023, 36 (03)